| Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy UH Gandhi, RF Cornell, A Lakshman, ZJ Gahvari, E McGehee, ... Leukemia 33 (9), 2266-2275, 2019 | 530 | 2019 |
| Clinical implications of targeting XPO1-mediated nuclear export in multiple myeloma UH Gandhi, W Senapedis, E Baloglu, TJ Unger, A Chari, D Vogl, ... Clinical Lymphoma Myeloma and Leukemia 18 (5), 335-345, 2018 | 124 | 2018 |
| Selenoprotein-dependent up-regulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor … UH Gandhi, N Kaushal, KC Ravindra, S Hegde, SM Nelson, V Narayan, ... Journal of Biological Chemistry 286 (31), 27471-27482, 2011 | 114 | 2011 |
| Thioredoxin reductase-1 negatively regulates HIV-1 transactivating protein Tat-dependent transcription in human macrophages P Kalantari, V Narayan, SK Natarajan, K Muralidhar, UH Gandhi, H Vunta, ... Journal of Biological Chemistry 283 (48), 33183-33190, 2008 | 97 | 2008 |
| Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer YC Chen, DM Sosnoski, UH Gandhi, LJ Novinger, KS Prabhu, AM Mastro Carcinogenesis 30 (11), 1941-1948, 2009 | 83 | 2009 |
| Δ12-prostaglandin J3, an omega-3 fatty acid–derived metabolite, selectively ablates leukemia stem cells in mice S Hegde, N Kaushal, KC Ravindra, C Chiaro, KT Hafer, UH Gandhi, ... Blood, The Journal of the American Society of Hematology 118 (26), 6909-6919, 2011 | 82 | 2011 |
| Gambogic acid covalently modifies IκB kinase-β subunit to mediate suppression of lipopolysaccharide-induced activation of NF-κB in macrophages UD Palempalli, U Gandhi, P Kalantari, H Vunta, RJ Arner, V Narayan, ... Biochemical Journal 419 (2), 401-409, 2009 | 78 | 2009 |
| Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxib D Desai, N Kaushal, UH Gandhi, RJ Arner, C D'Souza, G Chen, H Vunta, ... Chemico-biological interactions 188 (3), 446-456, 2010 | 70 | 2010 |
| Selenium suppresses leukemia through the action of endogenous eicosanoids UH Gandhi, N Kaushal, S Hegde, ER Finch, AK Kudva, MJ Kennett, ... Cancer research 74 (14), 3890-3901, 2014 | 40 | 2014 |
| Selenoproteins and their role in oxidative stress and inflammation U H Gandhi, T P Nagaraja, K Sandeep Prabhu Current chemical biology 7 (1), 65-73, 2013 | 27 | 2013 |
| Overall survival of patients with triple‐class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH R Cornell, P Hari, S Tang, N Biran, N Callander, A Chari, S Chhabra, ... American journal of hematology 96 (1), E5-E8, 2021 | 26 | 2021 |
| Selenium and inflammation N Kaushal, UH Gandhi, SM Nelson, V Narayan, KS Prabhu Selenium: its molecular biology and role in human health, 443-456, 2012 | 22 | 2012 |
| Overall survival of triple class refractory, penta-exposed multiple myeloma (MM) patients treated with selinexor plus dexamethasone or conventional care: a combined analysis of … LJ Costa, P Hari, SK Kumar, S Tang, UH Gandhi, JJ Shah, S Jagannath, ... Blood 134, 3125, 2019 | 13 | 2019 |
| Subsequent treatment outcomes of multiple myeloma refractory to CD38-monoclonal antibody therapy RF Cornell, UH Gandhi, A Lakshman, Z Gahvari, MH Jagosky, ... Blood 132, 2015, 2018 | 12 | 2018 |
| Natural history of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody-based treatment UH Gandhi, A Lakshman, Z Gahvari, E McGehee, MH Jagosky, R Gupta, ... Blood 132, 3233, 2018 | 9 | 2018 |
| Real world vs. clinical trial outcomes of triple class refractory penta-exposed multiple myeloma (MM) R Cornell, H Parameswaran, S Tang, A Barnstead, N Biran, N Callander, ... Clinical Lymphoma, Myeloma and Leukemia 19 (10), e115-e116, 2019 | 5 | 2019 |
| Selenium: Its Molecular Biology and Role in Human Health N Kaushal, UH Gandhi, SM Nelson, V Narayan, KS Prabhu | 5 | 2012 |
| Selenium status and erythropoiesis in mice N Kaushal, SN Hegde, UH Gandhi, RF Paulson, KS Prabhu The FASEB Journal 23, 728.5-728.5, 2009 | 3 | 2009 |
| Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells F Qian, SK Nettleford, J Zhou, BE Arner, MA Hall, A Sharma, ... Cell reports 42 (7), 2023 | 2 | 2023 |
| Compositions, methods and kits for treating cancer KS Prabhu, RF Paulson, S Hegde, N Kaushal, UH Gandhi US Patent 9,623,031, 2017 | 2 | 2017 |
